SDG Metadata

3-3-4

	Language	Translated	Untranslated	Untranslated words	Untranslated characters	Checks	Suggestions	Comments
	English MIT		0	0	0	25	0	0

	Arabic MIT	0%	26	4,299	29,505	3	0	0

	French MIT	0%	26	4,299	29,505	22	0	0

	Portuguese MIT	0%	26	4,299	29,505	0	0	0

	Russian MIT	0%	26	4,299	29,505	21	0	0

	Spanish MIT	0%	26	4,299	29,505	21	0	0

Please sign in to see the alerts.

Overview

Project website	github.com/worldbank/sdg-metadata
Instructions for translators	This project is limited to Russian translation only, for now. More detailed instructions to come.
Project maintainers	brockfanning
Translation process	Translations can be made directly. Translation suggestions are turned off. Any authenticated user can contribute. The translation uses monolingual files. The translation base language can not be edited.
Translation license	MIT License
Source code repository	`https://github.com/worldbank/sdg-metadata`
Repository branch	master
Last remote commit	Merge pull request #465 from brockfanning/phase-3-cleanup `6774727ddec` brockfanning authored yesterday
Last commit in Weblate	Translated using Weblate (Spanish) `af4385d5909` hernandanielmunoz authored a month ago
Weblate repository	`https://hosted.weblate.org/git/sdg-metadata/1-1-1a/`
Filemask	`translations-metadata/*/3-3-4.yml`
Monolingual base language file	`translations-metadata/en/3-3-4.yml`

String statistics

	Strings percent	Hosted strings	Words percent	Hosted words	Characters percent	Hosted characters
Total		156		25,794		177,030
Source		26		4,299		29,505
Translated	16%	26	16%	4,299	16%	29,505
Needs editing	42%	67	49%	12,731	49%	87,343
Failing checks	58%	92	66%	17,105	66%	117,354
Strings with suggestions	0%	0	0%	0	0%	0
Not translated strings	40%	63	33%	8,764	33%	60,182

Last year Previous

Activity in last 12 months


Sep	Oct	Nov	Dec	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug

Quick numbers

25,794

Hosted words

156

Hosted strings

16%

Translated

1

Contributors

and previous 30 days

Trends of last 30 days

+7%

Hosted words

—

+11%

Hosted strings

—

-47%

Translated

+13%

—

Contributors

-100%

Search

Advanced query builder

Query examples

Review strings changed by other users	`changed:>=2021-08-28 AND NOT changed_by:anonymous`	Add
Translated strings	`state:>=translated`	Add
Strings with comments	`has:comment`	Add
Strings with any failing checks	`has:check`	Add
Strings with suggestions from others	`has:suggestion AND NOT suggestion_author:anonymous`	Add
Approved strings with suggestions	`state:approved AND has:suggestion`	Add
All untranslated strings added the past month	`added:>=2021-08-28 AND state:<=needs-editing`	Add
Translated strings in a certain language	`is:translated AND language:en`	Add

None

New strings to translate

SDG Metadata / 3-3-4 — Russian

New strings to translate 3 days ago

None

New strings to translate

SDG Metadata / 3-3-4 — Portuguese

New strings to translate 3 days ago

None

New strings to translate

SDG Metadata / 3-3-4 — French

New strings to translate 3 days ago

None

New strings to translate

SDG Metadata / 3-3-4 — Spanish

New strings to translate 3 days ago

None

New strings to translate

SDG Metadata / 3-3-4 — Arabic

New strings to translate 3 days ago

None

Resource update

SDG Metadata / 3-3-4 — Russian

Resource update 3 days ago

None

Source string changed

SDG Metadata / 3-3-4 — Russian

3 days ago

None

Source string changed

SDG Metadata / 3-3-4 — Russian

<h2>Sources of discrepancies:</h2> <p>The estimates are not always the same as the official national estimates, because of the use of different methodologies and data sources. The study selection criteria were similar to (Schweitzer, et al., 2015)p>This dataset represents the best estimates for the hepatitis B surface antigen indicator and aims to facilitate comparability across countries and over time. The estimates are not always the same as the official national estimates, because of the use of different methodologies and data sources e.g. special populations or populations at risk are not included in the hepatitis b seroprevalence model. Estimates are provided for 194 WHO Member States. The conditional autoregressive model uses data from well sampled countries to estimate prevalence in more data-poor countries taking account of effects such as sex, age and vaccination status. Due to scarcity of data from some countries, the estimates are more robust at global and regional level than at country level, therefore focus should be on the 95% Credible Intervals and not only on the reported point estimates.</p>
<p>Sources of discrepancies:</p>
<p>Inclusion or exclusion criteria of the type of seroprevalence studies. Observational studies on chronic HBV infection seroprevalence (HBsAg prevalence), done in the general population or among blood donors, health-care workers (HCWs), and pregnant women were considered for inclusion ~~in this systematic review~~. Studies were excluded if they were systematic reviews or meta-analyses, surveillance reports, case studies, letters or correspondence, or did not contain HBsAg seroprevalence data. Studies were also excluded if they exclusively reported prevalence estimates for high-risk population groups (e.g., migrants and refugees). ~~Country estimates may come from selected serosurveys.~~</p>

3 days ago

None

Source string changed

SDG Metadata / 3-3-4 — Russian

<h1p>Data availability~~</h1> <h2>Description:</h2~~: </p>
<p>Estimates are available for 194 Member States and for the six WHO Regions, as well as at global level.</p>
<h2p>Time series:</h2p>
<p>Estimates are available for pre- vaccine era, 2015 and 201~~7 estimates are in review process.~~8 and 2020 </p>
<h2p>Disaggregation:</h2p>
<p>Aage groups (i.e. under five years of age, 5 years and older (although these estimates are not reported) and the general population); sex/gender if possible. Although the data for the latter is scarce. In addition, data at national, regional and global level. </p>
<p> </p>

3 days ago

None

Source string changed

SDG Metadata / 3-3-4 — Russian

<h2p><strong>Quality assurance~~:</h2~~</strong> </p>
<ul>
<li>WHO’s estimates use a methodology reviewed by the Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) and presented to the Strategic Advisory Group of Experts (SAGE). These estimates have been documented following the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).</li>
</ul>
<p> </p>
<ul>
<li>WHO provided Member States the opportunity to review and comment on data and estimates as part of the so called country consultation process.</li>
</ul>

3 days ago

Browse all component changes